Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | UTS2R | Q9UKP6 | 3/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20108098 | 0.82 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CHRM1CHRNB2 | |
| SCHEMBL15111650 | 0.79 | CA1 (0.42) | CHRM1CHRNB2CHRM3CHRNA4MEN1 | |
| SCHEMBL19085523 | 0.79 | TSHR (0.32) | MEN1KMT2AUTS2R | |
| SCHEMBL4954690 | 0.77 | TSHR (0.39) | MEN1KMT2ACA1CA2SMN1; SMN2 | |
| SCHEMBL15111700 | 0.76 | CA2 (0.53) | CA1CA2ZDHHC7 | |
| SCHEMBL23483674 | 0.75 | CA1 (0.37) | CHRM2CHRM4CHRM5CHRM1CHRNB2 | |
| SCHEMBL3274327 | 0.74 | ZDHHC7 (0.53) | CA1CA2ZDHHC7 | |
| SCHEMBL13955398 | 0.74 | CYP2C9 (0.40) | KMT2A | |
| SCHEMBL13895351 | 0.74 | — | — | |
| SCHEMBL6272993 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4289951-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| WO-2021030701-A1 | IMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS | Acuitas Therapeutics, Inc. (CA) | 2021-02-18 | — | — | WO | disclosed |